Pharmaceuticals News 25 November 2025

AbbVie (ABBV) Stock on November 29, 2025: Skyrizi’s Canada Win, Big-Money Flows and a Hot Valuation Debate

Published: November 29, 2025 AbbVie Inc. (NYSE: ABBV) heads into the final stretch of 2025 trading just below its record highs, after a powerful rally driven by immunology blockbuster drugs Skyrizi and Rinvoq. The stock closed at $227.70 on Friday,

29 November 2025

Eli Lilly (LLY) Stock Today: Trillion‑Dollar Weight‑Loss Giant Pulls Back After November Surge

By [Author Name] – November 29, 2025 Eli Lilly and Company’s stock has cooled after an explosive November rally that briefly turned the 149‑year‑old drugmaker into the world’s first trillion‑dollar pharmaceutical company. Reuters+1 On Friday, November 28, Eli Lilly (NYSE:

29 November 2025

Financial Analysis · Investment News · NYSE:LLY · Pharmaceuticals · Stock Market · Weight Loss

Johnson & Johnson Stock (JNJ) Near Record Highs: Halda Deal, Spin‑Off Plans and Talc Risks on November 28, 2025

Updated: November 28, 2025 Johnson & Johnson (JNJ) is closing out 2025 as one of the standout “defensive” winners in the U.S. market. The stock is trading just below a fresh 52‑week high around $205–$208 per share, giving the healthcare

28 November 2025

Corporate Strategy · Investment Analysis · Legal Risks · Pharmaceuticals · Stock Market

Pfizer Stock Today (PFE), November 28, 2025: Guggenheim Upgrade, Norges Bank Stake and a 6.7% Dividend Yield

Published: November 28, 2025 – mid‑session U.S. trading Pfizer stock price today: PFE edges higher in midday trade Pfizer stock (NYSE: PFE) is trading around $25.8 per share in late morning trading on Friday, November 28, 2025, up roughly 0.3%

28 November 2025

Dividend Stocks · Financial Analysis · Investment News · NYSE:PFE · Pharmaceuticals · Stock Market

GSK plc Stock Today, 28 November 2025: Buybacks, ‘Hold’ Ratings and Pipeline Momentum Keep Shares Near Highs

GSK plc (LON:GSK; NYSE:GSK) is drifting quietly higher on Friday, 28 November 2025, with investors digesting a fresh “Hold” consensus from Wall Street, another round of share buybacks and a still‑busy drug pipeline that has pushed the stock close to

28 November 2025

Company News · Financial Trends · Investment Analysis · NYSE:GSK · Pharmaceuticals · Stock Market

Novo Nordisk (NVO) Stock Rebounds as Wegovy Upgrade and Medicare Deal Ease Pricing Fears – 26 November 2025

Novo Nordisk A/S stock is staging a sharp rebound today, 26 November 2025, as investors digest a trio of major developments: an FDA filing for a higher-dose version of its blockbuster obesity drug Wegovy, clarity on steep—but largely expected—Medicare price

26 November 2025

Financial Analysis · Healthcare · Investment News · Pharmaceuticals · Stock Market

Pfizer Stock Today, November 26, 2025: Obesity Bet, Cancer Breakthrough and Legal Risks Shape PFE’s Outlook

Pfizer Inc. (NYSE: PFE) spent Wednesday trading slightly lower despite a stream of fresh headlines that cut both ways for sentiment. The stock hovered around $25.7, giving back a fraction of Tuesday’s nearly 2% gain, as investors weighed upbeat news

26 November 2025

Cancer Research · Legal Issues · NYSE:PFE · Obesity · Pharmaceuticals · Stocks

Merck (MRK) Stock Today – November 26, 2025: Keytruda Wins, Analyst Upgrades and Big Money Buying Keep Shares Near Record Highs

Merck & Co., Inc. (NYSE: MRK) spent Wednesday trading just below fresh 52‑week highs, as Wall Street continues to digest a powerful mix of positive drug news, upbeat earnings, and a wave of analyst upgrades and institutional buying. Merck stock

26 November 2025

Analyst Ratings · Financial News · Investment · NYSE:MRK · Pharmaceuticals · Stock Market

Pfizer (PFE) Stock Today, November 26, 2025: Options Surge, Obesity Bet and Cancer Win Shape the Outlook

Pfizer Inc. (NYSE: PFE) heads into Wednesday, November 26, 2025 with its share price sitting just under the top of its recent trading range and a narrative that looks very different from the COVID‑era boom and bust. After climbing almost

26 November 2025

Financial Analysis · Health Trends · Investment Strategies · NYSE:PFE · Pharmaceuticals · Stock Market

Merck (MRK) Stock Soars on FDA Keytruda Approval and Wells Fargo Upgrade – 25 November 2025

Merck & Co., Inc. (NYSE: MRK) is back in the market’s spotlight this Tuesday, with the pharmaceutical giant’s shares extending a powerful rally fuelled by fresh regulatory wins and a major Wall Street upgrade. As of early-afternoon trading on 25

25 November 2025

Company Upgrades · FDA Approval · Investment News · NYSE:MRK · Pharmaceuticals · Stock Market

NVO Stock Today: Novo Nordisk Rebounds on New Weight‑Loss Drug Data After Alzheimer’s Blow (Nov. 25, 2025)

Key takeaways NVO stock today: price and trading snapshot (Nov. 25, 2025) As of late‑afternoon trading on Tuesday, November 25, 2025, Novo Nordisk A/S American Depositary Receipts (ADR), ticker NVO on the NYSE, were changing hands at about $47.08, up

25 November 2025

Drug Research · Novo Nordisk · Pharmaceuticals · Stock Market · Weight Loss

Eli Lilly (LLY) Stock Today: $1 Trillion Pharma Giant Extends Rally on Bernstein Upgrade and GLP‑1 Momentum – 25 November 2025

INDIANAPOLIS — November 25, 2025 — Eli Lilly and Company (NYSE: LLY) continued its remarkable run on Tuesday, as the first-ever $1 trillion pharmaceutical company saw its stock climb again on the back of fresh analyst upgrades, intensifying obesity-drug momentum

25 November 2025

Company Analysis · Financial Updates · Investment News · NYSE:LLY · Pharmaceuticals · Stock Market

Pharmaceuticals News 25 November 2025 - 29 November 2025